Abstract: A method for the manufacture of an electrochromic system using a nanoporus-nanocrystalline film comprising a semiconducting metallic oxide having a redox chromophore adsorbed thereto.

Abstract: Magnetic tunneling junction devices (MTJ) useful for sensing and memory applications and characterized by reduced resistance, magnetic noise, increased sensitivity, and increased magnetoresistance are disclosed herein. A method for fabrication of said MTJ is also disclosed wherein a series of materials are layered upon a substrate under controlled conditions, patterned and subjected to a period of annealing for simultaneously optimizing a plurality of performance parameters.

Abstract: New compounds useful in photodynamic therapy are of the formula and their 1,4-diene isomers and the metallated and/or labeled and/or conjugated forms thereof wherein each R1 is independently alkyl (1-6C); each n is independently an integer of 0-6; and R2 is vinyl or a derivative form thereof.

Abstract: A system for tomographic sounding using infrared radiation, said system comprising a plurality of gas correlation cameras, each of said cameras comprising at least two gas correlation cells, one of said cells filled with a first gas capable of absorbing infrared radiation at one infrared band and another of said cells filled with a second first gas capable of absorbing infrared radiation at another inked band, and a camera with imaging optics for determining both the spectral and energy content of said first infrared band and the spectral and energy content of said second infrared band.

Abstract: A method of treating a subject infected with a virus or a method of preventing viral infection of a subject comprising administering to the subject an effective amount of a compound having the structure: wherein L=L′=2-methylimidazole.

Abstract: A method and compositions for treating persistent pulmonary hypertension in human newborns that deploys an intravenous infusion of a modified drug formed by adding one or more of a predetermined chemical arrangement to an efficacious parent drug compound so as to retain efficacy while re-directing a preferred route and rate of the parent drug compound's metabolism to an inactive or very weakly active and non-toxic metabolite are disclosed.

Abstract: The present invention relates to a method for detecting a line-to-ground fault location in power network, and more particularly, detecting the line-to-ground fault location by direct 3-phase circuit analysis without using a symmetrical component transformation, so even in an unbalanced 3-phase circuit, the line-to-ground fault location can be accurately detected. In the method using direct 3-phase circuit analysis of this invention, inverse lemma is used to simplify matrix inversion calculations, thus the line-to-ground fault location can be easily and accurately determined even in the case of an unbalanced network without symmetrical component transformation.

Abstract: The present invention provides a system, method and apparatus for parallel information transmission in wireless communication systems. More specifically, the present invention provides a method of transmitting information over a transmission medium by receiving a set of serial symbols or bits representing the information to be transmitted during a frame (502), encoding the set of serial symbols or bits into one or more sets of parallel channel symbols or bits (504), and transmitting the one or more sets of parallel channel symbols or bits the frame (506). The present invention also provides a method of receiving information over a transmission medium by receiving a set of parallel channel symbols or bits during a frame (1302) and decoding the set of parallel channel symbols or bits into a set of serial symbols or bits representing the information transmitted (1304).

Abstract: Novel compounds which selectively bind to the &dgr;-opioid receptor have been designed. These compounds have greater selectivity, improved water (blood) solubility, and enhanced therapeutic value as analgesics. Because agonists with selectivity for the &dgr;-opioid receptor have shown promise in providing enhanced analgesis without the addictive properties, the compounds of the present invention are better than morphine, naltrindole (NTI), spiroindanyloxymorphone (SIOM), and other known &mgr;-opioid receptor selectors as analgesics.

Abstract: A peel and stick electronic system comprises a silicone body, and at least one electronic unit operatively connected to the silicone body. The electronic system is produce by providing a silicone layer on a substrate, providing a metal layer on the silicone layer, and providing at least one electronic unit connected to the metal layer.

Abstract: The present invention relates to a novel I-FLICE-1 or I-FLICE-2 protein which is a novel inhibitor of TNFR-1 and CD-95 induced apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human I-FLICE-1 or I-FLICE-2 protein. I-FLICE-1 or I-FLICE-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of I-FLICE-1 or I-FLICE-2 activity. Also provided are therapeutic methods for treating diseases and disorders associated with apoptosis.

Abstract: The present invention provides for methods of quantitating the amounts of proteins or peptides, including those that are closely related isoforms, using matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). Measurement of protein concentrations in vivo has been extremely difficult and problematic, and protein concentrations have not been shown to correlate well with mRNA levels, the standard used in the past. The present invention overcomes the deficiencies of prior methodologies by taking advantage of MALDI-TOF-MS technology and applying it to proteins and peptides in a way that allows for accurate, quantitative measurement in vivo of protein or peptide concentrations.

Abstract: A manufacturing apparatus and method of a fiber coupler is provided. A movable electric arc is employed to fuse more than two stacked fibers for manufacturing a fiber coupler having a small size and good environment stability. It is advantageous that the fiber coupler can be used in a SDH (Synchronous Digital Hierarchy) communication system, and the method also be used to manufacture the all-fiber CWDM (Coarse Wavelength Division Multiplexing) multiplexer which covers the E-band wavelengths and the sub-components of the OADM (Optical Add/Drop Multiplexer). And, all these functions are difficult to be achieved by the conventional techniques.

Abstract: Diagnostic and therapeutic applications for certain types of cancer and precancerous conditions, including those deriving from hematologic cells, are described. Of particular interest are those cancers and precancerous conditions associated with increased signaling in the RAS-MAP kinase pathway. The diagnostic and therapeutic applications described herein are based on certain mutations in the protein tyrosine phosphatase gene PTPN11 and its expression product, PTPN11, promoting a gain-of-function in PTPN11 activity. Also described are nucleotide sequences, amino acid sequences, probes, and primers related to PTPN11 and PTPN11 variants, and cells expressing such variants.

Abstract: The invention provides a method of alleviating neuropathic pain in a subject by administering a neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The invention also provides a method of inhibiting the onset of neuropathic pain in a subject by administering neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The present invention also provides prosaposin receptor agonists and the use of these agonists for stimulating neurite outgrowth, inhibiting neural cell death, promoting myelination and inhibiting neural demyelination. In addition, there is provided a method of inhibiting sensory or motor neuropathy by contacting neuronal cells with a composition comprising an effective inhibiting amount of prosaposin receptor agonist.

Abstract: The designing methods for an impedance matching are provided which include steps of: connecting in parallel a capacitor to a collector/drain of a bipolar/field effect transistor having a common-emitter configuration, and obtaining a desired resistance at a base/gate of the bipolar/field effect transistor due to a feedback effect for achieving the impedance matching. The circuits for an impedance matching are also provided which include: a first bipolar/field effect transistor, an inductor, a first resistor, a power supply, a capacitor, a second bipolar/field effect transistor, a second resistor, and a third resistor, wherein a desired resistance is produced in the input impedance looking into the base/gate of the first bipolar/field effect transistor through an equivalent parallel combination of an capacitor and an resistor produced at the base/gate of the second bipolar/field effect transistor so as to achieve the impedance matching.

Abstract: A thermoplastic polymer composition reinforced with fibers such as cellulose or other fillers, particularly from natural sources, and a process for manufacturing the composition are disclosed. The preferred process for making the fiber-reinforced thermoplastic polymer composition comprises melting a high melting temperature thermoplastic polymer, mixing the melted thermoplastic polymer with an organic or inorganic salt to reduce the melting temperature of the melted thermoplastic polymer to a melting temperature which does not degrade the fibers, and then adding the fibers to the reduced melting temperature thermoplastic polymer-salt mixture to produce the natural fiber-reinforced thermoplastic polymer composition. The natural fiber-reinforced thermoplastic polymer composition can then be melted at the reduced melting temperature to manufacture a plurality of articles.

Abstract: Disclosed are methods for the isolation and purification of high-titer recombinant adeno-associated virus (rAAV) compositions. Also disclosed are methods for reducing or eliminating the concentration of helper adenovirus in rAAV samples. Methods are disclosed that provide highly-purified rAAV stocks having titers up to about 1013 particles/ml at particle-to-infectivity ratios of less than 100 in processes that are accomplished about 24 hours or less.

Abstract: Methods, systems, and media relating the display of scattering and/or absorption characteristics of an optical medium. For scattering measurements, a Hartmann-Shack calibration image of a measurement system is acquired to define a first plurality of point spread functions. A Hartmann-Shack test image of the medium is acquired to define a second plurality of point spread functions. A shift is determined between the test image and the calibration image. A point spread of each of the second plurality of point spread functions is measured, each of the second plurality of point spread functions including a component due to optical aberration of the medium and a component due to scatter. The component due to optical aberration is determined using the shift. The component due to optical aberration is deconvolved to determine the component due to scatter. A display of the local scattering characteristics is generated using the component due to scatter.